ArticleScientific reports2025
Assessing knowledge, attitudes, and barriers toward HPV cervical cancer and vaccination among female university students in Bangladesh.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- RRM2/GCH1 signaling decreased cisplatin sensitivity in cervical cancer by modulating the ferroptosis process.Histology and histopathology · 2026Article
- HPV Vaccination Knowledge and Awareness Among Male University Students in Malaysia: A Cross-Sectional Study.Vaccines · 2026Article
- Awareness, factual knowledge, attitudes, and acceptability of human papillomavirus vaccination among adult women in Palestine: a cross-sectional study.Frontiers in global women's health · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human papillomavirus (HPV) is a leading cause of genital warts and cervical cancer (CC), which was reported as the second most common malignancy among women in Bangladesh in 2020. While vaccination against HPV stands out as the most effective strategy for preventing CC, however, misconceptions about its safety, effectiveness, and benefits may impact its prevalence. This study aimed to evaluate the knowledge of HPV infection, CC, and vaccination, as well as the attitudes and willingness to receive the vaccine among female university students in Bangladesh. A cross-sectional survey was conducted to collect primary data from 800 university students through face-to-face interviews. A well-structured questionnaire was administered to collect data on socio-demographic characteristics, knowledge of HPV infection, CC, and vaccination, as well as attitudes and willingness regarding vaccination. Multivariable logistic regression was used to identify factors influencing knowledge about HPV infection and CC. Moreover, Structural Equation Modeling (SEM) explored direct and indirect pathways affecting knowledge, attitudes, and willingness, validated by goodness-of-fit indices. Students with sexual health education demonstrated higher awareness of HPV infection and cervical cancer, with 23.4% having good knowledge, compared to only 11.0% without such education. Difficulty accessing healthcare increased the odds of poor knowledge in the unadjusted model (COR: 1.72. 95% CI: 1.01-2.93), whereas students from Khulna had higher odds (AOR: 4.45, 95% CI: 1.24-15.88). Moreover, 44.8% of participants recognized that the HPV vaccine prevents cervical cancer, and 64.7% were unsure of its effectiveness. The SEM highlights that attitude is the strongest predictor of vaccination willingness (0.61), while HPV vaccination knowledge has a moderate impact (0.46). University female students have limited knowledge about HPV, CC, and vaccination, yet they are willing to receive the HPV vaccine. This highlights the need for the government to implement educational initiatives and health counseling to increase awareness and empower informed health decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.